4/A: OpGen Inc. Director David E. Lazar Acquires Additional Series E Convertible Preferred Stock

Sentiment:

SEC Form 4/A


David E. Lazar, a director and 10% owner of OpGen Inc., acquired an additional 150,000 shares of Series E Convertible Preferred Stock on April 23, 2024.

Summary

  • David E. Lazar, a director, 10% owner, and Chief Executive Officer of OpGen Inc., filed an amended Form 4/A with the SEC.
  • The filing reports the acquisition of 150,000 shares of Series E Convertible Preferred Stock on April 23, 2024, for $150,000.
  • This is part of a larger agreement where Lazar will acquire 3,000,000 shares of Series E Preferred Stock at $1.00 per share.
  • Each share of Series E Preferred Stock is convertible into 24 shares of OpGen's Common Stock, subject to ownership limitations.
  • The initial closing occurred on March 25, 2024, with Lazar acquiring 200,000 shares.
  • The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.
  • This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects an insider's investment, which can be seen as a positive signal, but it's also a structured transaction that may have specific motivations beyond pure optimism.

Positives

  • A director and significant shareholder is increasing their investment in the company, which could signal confidence in OpGen's future prospects.

Future Outlook

The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

Industry Context

This filing reflects insider activity, which is closely monitored by investors for signals about a company's prospects. The purchase of preferred stock, convertible into common stock, suggests a long-term investment perspective.

Stakeholder Impact

  • The acquisition of shares by a director and significant shareholder could positively influence investor confidence.

Key Dates

DateDescription
03/25/2024Initial closing of the securities purchase agreement, with Lazar acquiring 200,000 shares of Series E Preferred Stock.
04/23/2024Lazar acquired an additional 150,000 shares of Series E Preferred Stock.
04/25/2024Date of Original Filed.
05/20/2024Effective date of the reverse stock split of OpGen's Common Stock.
08/01/2024Date of signature for the Form 4/A.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.